Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
University of Michigan · Michigan Medicine · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
641
total citations
- FWCI
- 51.29
- Percentile
- 100%
- References
- 35
Citations per year
Authors
99Topics & keywords
Topics
Keywords
- Medicine
- Tocilizumab
- Placebo
- Double blind
- Clinical trial
- MEDLINE
- Internal medicine
- Alternative medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.